Insider · CIK 0001785794
Carol R. Lizak
Files at JAGX (Jaguar Health, Inc.). First filing -, latest -.
In brief
Carol R. Lizak files SEC Form 4 as CFO at JAGX (Jaguar Health, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Carol R. Lizak has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | JAGX Jaguar Health, Inc. | AGrant or award Common Stock | +11,740 | $0.00 | $0 | 11,911 | Dec 15, 2025 |
| Dec 11, 2025 | JAGX Jaguar Health, Inc. | AGrant or award Stock Option (right to buy)derivative | +11,740 | $0.00 | $0 | 11,740 | Dec 15, 2025 |
| Mar 31, 2025 | JAGX Jaguar Health, Inc. | POpen-market purchase Convertible Promissory Notederivative | +5,400 | $30,000.00 | $162M | 5,400 | Apr 2, 2025 |
| Mar 31, 2025 | JAGX Jaguar Health, Inc. | POpen-market purchase Warrant to Purchase Common Stockderivative | +5,400 | - | - | 5,400 | Apr 2, 2025 |
Questions about Carol R. Lizak
Answered from the filings on this page, as of the latest one.
Is Carol R. Lizak buying or selling?
Carol R. Lizak has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Carol R. Lizak's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Carol R. Lizak has 0.
Where does Carol R. Lizak file Form 4?
Carol R. Lizak has filed Form 4 at JAGX (Jaguar Health, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.